X

Xenon Pharmaceuticals
D

XENE

30.689
USD
-0.72
(-2.30%)
مغلق
حجم التداول
0
الربح لكل سهم
-4
العائد الربحي
-
P/E
-10
حجم السوق
2,349,022,327
أصول ذات صلة
A
AKRO
-1.940
(-4.63%)
39.980 USD
AMGN
AMGN
4.42
(1.45%)
310.04 USD
A
ARCT
-0.71500
(-7.01%)
9.48500 USD
BIIB
BIIB
-0.630
(-0.48%)
130.690 USD
F
FULC
-0.29000
(-10.23%)
2.54500 USD
GOOGL
GOOGL
-6.220
(-3.96%)
150.710 USD
المزيد
الأخبار المقالات

العنوان: Xenon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.